(Q48909874)
Statements
Preferential vulnerability of nucleus accumbens dopamine binding sites to low-level lead exposure: time course of effects and interactions with chronic dopamine agonist treatments (English)
M J Pokora
E K Richfield
D A Cory-Slechta
1 October 1996